Table 4.
Effect of various therapies for metastatic adrenal tumor from HCC
| Treatment | Author | Time | Case (n) | Tumor | Survival time (from Treatment of adrenal metastases) | ||
|---|---|---|---|---|---|---|---|
| Median (months) | Survival rate (1 year) | Survival rate (2 years) | |||||
| Surgery | Momoi H [5] | 2002 | 13 | 8/13 have additional organs metastases. | 51.3% | 42% | |
| Park JS [6] | 2007 | 5 | With well-controlled intrahepatic foci no additional organs metastases | 21.4 | 100% | 50% | |
| Single adrenal metastases | |||||||
| TACE | Momoi H [5] | 2002 | 4 | With tumor thrombus or additional organs metastases | 5.9, 6.5, 16.1, 21.3 months | ||
| Taniai N [18] | 1999 | 2 | Single adrenal metastases and well-controlled intrahepatic foci | Survived 3 and 8 months (still live) | |||
| PEIT | Momoi H [5] | 2002 | 4 | additional organs metastases (1 case), intrahepatic tumor (3 case) | 7.6, 8.5, 21.4, 32 months | ||
| PEIT + TACE | Park JS [6] | 2007 | 19 | well-controlled intrahepatic foci, no additional organs metastases | 10.5 | 43 | 0 |
| RF+ TACE | Yamakado K [19] | 2009 | 6 | intrahepatic tumor (T3), additional organs metastases (3 cases), size of metastatic adrenal tumor (3-8 cm) | 24.9 | ||
| No treatment | Park JS [6] | 2007 | 6 | well-controlled intrahepatic foci, no additional organs metastases | 5.6 | 0% | - |
| RT | Zhou LY | 2014 | 55 | Patients of liver function Child-Pugh C were excluded | 13.6 | 58.7% | 32.3% |